These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 19401613

  • 1. The effects of Helicobacter pylori eradication on body mass index and dyspeptic symptoms.
    Suto H, Yamazaki Y, Yoshida I, Yamakawa A, Ohtani M, Ito Y, Kuriyama M, Kato T, Azuma T.
    Digestion; 2009; 79(4):235-42. PubMed ID: 19401613
    [Abstract] [Full Text] [Related]

  • 2. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 4. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
    Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, Ishii H, Kangawa K, Hibi T.
    Hepatogastroenterology; 2005 Nov; 52(61):1-4. PubMed ID: 15782980
    [Abstract] [Full Text] [Related]

  • 5. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
    Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Franzé A, Rugge M.
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
    [Abstract] [Full Text] [Related]

  • 6. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 7. [Helicobacter pylori and the development of atrophic gastritis].
    Takahashi S, Igarashi H, Masubuchi N, Ishiyama N, Saito S, Aoyagi T, Itoh T, Hirata I.
    Nihon Rinsho; 1993 Dec; 51(12):3231-5. PubMed ID: 8283639
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.
    Kang JM, Kim N, Shin CM, Lee HS, Lee DH, Jung HC, Song IS.
    Helicobacter; 2012 Apr; 17(2):86-95. PubMed ID: 22404438
    [Abstract] [Full Text] [Related]

  • 9. Serum pepsinogens as an early diagnostic marker of H. pylori eradication.
    Shirai N, Furuta T, Sugimoto M, Kanaoka S, Watanabe F, Takashima M, Yamada M, Futami H, Sato Y, Kubota H, Kodaira M, Kajimura M, Maekawa M, Hishida A.
    Hepatogastroenterology; 2008 Apr; 55(82-83):486-90. PubMed ID: 18613393
    [Abstract] [Full Text] [Related]

  • 10. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N, Katsuragi K, Maeda K, Sawada T, Wakasa K, Hirakawa K.
    Hepatogastroenterology; 2006 Apr; 53(70):619-23. PubMed ID: 16995475
    [Abstract] [Full Text] [Related]

  • 11. Examination of serum pepsinogen in functional dyspepsia.
    Tahara T, Shibata T, Okubo M, Yamashita H, Yoshioka D, Yonemura J, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Nakamura M, Arisawa T, Hirata I.
    Hepatogastroenterology; 2012 Apr; 59(120):2516-22. PubMed ID: 23178618
    [Abstract] [Full Text] [Related]

  • 12. The effect of Helicobacter pylori eradication on dyspeptic symptoms, acid reflux and quality of life in patients with functional dyspepsia.
    Bektas M, Soykan I, Altan M, Alkan M, Ozden A.
    Eur J Intern Med; 2009 Jul; 20(4):419-23. PubMed ID: 19524187
    [Abstract] [Full Text] [Related]

  • 13. Nonulcer dyspepsia and Helicobacter pylori eradication in children.
    Farrell S, Milliken I, Murphy JL, Wootton SA, McCallion WA.
    J Pediatr Surg; 2005 Oct; 40(10):1547-50. PubMed ID: 16226982
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of Helicobacter pylori infection, endoscopic gastric findings and dyspeptic symptoms among a young Japanese population born in the 1970s.
    Shimatani T, Inoue M, Iwamoto K, Hyogo H, Yokozaki M, Saeki T, Tazuma S, Horikawa Y.
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1352-7. PubMed ID: 16105120
    [Abstract] [Full Text] [Related]

  • 15. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY, Baik HW.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection.
    Kakushima N, Fujishiro M, Yahagi N, Kodashima S, Nakamura M, Omata M.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1586-9. PubMed ID: 16928221
    [Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease.
    Weck MN, Gao L, Brenner H.
    Epidemiology; 2009 Jul; 20(4):569-74. PubMed ID: 19404195
    [Abstract] [Full Text] [Related]

  • 18. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.
    Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, Tanaka S, Yoshihara M.
    Aliment Pharmacol Ther; 2003 Jul 15; 18(2):245-52. PubMed ID: 12869086
    [Abstract] [Full Text] [Related]

  • 19. Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan.
    Kawai T, Miki K, Ichinose M, Kenji Y, Miyazaki I, Kawakami K, Kataoka M, Yamagishi T, Sofuni A, Itoi T, Moriyasu F, Takagi Y, Aoki T, Matsubayashi J, Mukai K.
    Inflammopharmacology; 2007 Feb 15; 15(1):31-5. PubMed ID: 17323193
    [Abstract] [Full Text] [Related]

  • 20. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A.
    Dig Liver Dis; 2005 Jul 15; 37(7):501-8. PubMed ID: 15975537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.